Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.

Filiaciones

Pinana, JL:

1 Hematology Department, Hospital Clínico Universitario de Valencia, Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain.

Vázquez L:

2 Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.

Martino R:

3 Hematology Department, Hosptital de la Santa Creu i Sant Pau, Barcelona, Spain.

de la Cámara R:

4 Hematology Department, Hospital de la Princesa, Madrid, Spain.

Sureda A:

5 Hematology Department, Hematology Department, Institut Català d'Oncologia-Hospitalret, IDIBELL, Universitat de Barcelona, Barcelona, Spain.

Rodríguez-Veiga R:

6 Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Garrido A:

3 Hematology Department, Hosptital de la Santa Creu i Sant Pau, Barcelona, Spain.

Sierra J:

3 Hematology Department, Hosptital de la Santa Creu i Sant Pau, Barcelona, Spain.

Ribera JM:

7 Clinical Hematology Department, ICO-Hospital Germans Trias i Pujol. Josep Carreras Research Institute, Badalona, Spain.

Torrent A:

5 Hematology Department, Hematology Department, Institut Català d'Oncologia-Hospitalret, IDIBELL, Universitat de Barcelona, Barcelona, Spain.

Mateos MV:

2 Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.

de la Rubia J:

6 Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Tormo M:

1 Hematology Department, Hospital Clínico Universitario de Valencia, Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain.

Díez-Campelo M:

2 Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.

García-Gutiérrez V:

8 Hematology Department, Hospital Universitario Ramón y Cajal. IRYCIS, Madrid, Spain.

Álvarez-Larrán A:

9 Hematology Department, Hospital Clinic, IDIBAPS, Barcelona, Spain.

Sancho JM:

8 Hematology Department, Hospital Universitario Ramón y Cajal. IRYCIS, Madrid, Spain.

MartínGarcía-Sancho A:

2 Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.

Yanez, L:

10 Hematology Department, Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain.

Pérez Simón JA:

11 Hematology Department, Hospital Virgen del Rocio, Sevilla, Spain.

Barba P:

12 Hematology Department, Hospital Universitario Vall d´Hebron, Barcelona, Spain.

Abrisqueta P:

12 Hematology Department, Hospital Universitario Vall d´Hebron, Barcelona, Spain.

Álvarez-Twose I:

13 Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast) and CIBERONC, Hospital Virgen del Valle, Toledo, Spain.

Bonanad S:

6 Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.

Lecumberri R:

14 Hematology Service, Clínica Universidad de Navarra, Pamplona, Spain.

15 CIBER-CV, Instituto de Salud Carlos III, Madrid, Spain.

Ruiz-Camps I:

16 Infectious disease department, Hospital Universitario Vall d´Hebron, Barcelona, Spain.

Navarro D:

17 Department of Medicine, School of Medicine, Microbiology Service, Hospital Clínico Universitario, University of Valencia, Valencia, Spain.

Hernández-Rivas JÁ:

18 Hematology Department, Infanta Leonor University Hospital. Complutense University, Madrid, Spain.

Cedillo Á:

1 Hematology Department, Hospital Clínico Universitario de Valencia, Fundación INCLIVA, Instituto de Investigación Sanitaria Hospital Clínico Universitario de Valencia, Valencia, Spain.

García-Sanz R:

2 Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain.

Bosch F:

12 Hematology Department, Hospital Universitario Vall d´Hebron, Barcelona, Spain.